Introduction of New Guidelines

The release of the 2024 ADA consensus guidelines is a significant advancement in managing diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), updating recommendations that had been in place since 2009. This new set of guidelines incorporates research and recommendations from various international diabetic organizations, reflecting a more comprehensive approach to patient management. Key updates include the recognition of euglycemic DKA and new treatment management protocols, which are essential for both emergency and primary care providers. These updated guidelines serve to enhance clinical practice and improve patient outcomes, particularly in patients experiencing complex hyperglycemic crises.